TickerFacts.

Tenax Therapeutics, Inc. (TENX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$11.39M
Year ended 2022-12-31
2011-04-30: -$8.64M2012-04-30: -$8.30M2013-04-30: -$4.94M2014-04-30: -$9.27M2015-04-30: -$9.75M2016-12-31: -$15.87M2017-12-31: -$12.15M2018-12-31: -$5.51M2019-12-31: -$7.56M2020-12-31: -$9.28M2021-12-31: -$10.86M2022-12-31: -$11.39M-$11.39M
2011-04-30 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$11.39Mn/c2024-03-28, From 2022-01-01
2021-12-31-$10.86Mn/m2023-03-31, From 2021-01-01
2020-12-31-$9.28Mn/m2022-03-29, From 2020-01-01
2019-12-31-$7.56Mn/m2021-04-16, From 2019-01-01
2018-12-31-$5.51Mn/m2020-03-30, From 2018-01-01
2017-12-31-$12.15Mn/m2019-04-01, From 2017-01-01
2016-12-31-$15.87Mn/a2018-04-02, From 2016-01-01
No annual figure between 2015-04-30 and 2016-12-31.
2015-04-30-$9.75Mn/m2017-03-16, From 2014-05-01
2014-04-30-$9.27Mn/m2017-03-16, From 2013-05-01
2013-04-30-$4.94Mn/m2014-07-29, From 2012-05-01
2012-04-30-$8.30Mn/m2013-06-26, From 2011-05-01
2011-04-30-$8.64Mn/a2012-07-25, From 2010-05-01